Evaluating an adaptive and interactive mhealth smoking cessation and medication adherence program: A randomized pilot feasibility study

JMIR mHealth and uHealth

Volumn 4, Issue 3, 2016, Pages

  McClure, Jennifer B ^a   Anderson, Melissa L ^a   Bradley, Katharine ^a   An, Lawrence C ^b   Catz, Sheryl L ^c  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EHealth; MHealth; Mobile health; Secure messaging; Smoking; Tobacco use cessation; Varenicline

Indexed keywords

EID: 85014009841     PISSN: None     EISSN: 22915222     Source Type: Journal    
DOI: 10.2196/mhealth.6002     Document Type: Article

References (46)

1. WHO Report on the Global Tobacco Epidemic, 2015: Raising Taxes on Tobacco. Geneva, Switzerland: World Health Organization; 2015. URL: http://apps.who.int/iris/bitstream/10665/178574/1/9789240694606_eng.pdf?ua=1&ua=1 [accessed 2016-07-24]
2. Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged 18 years and older, United States, 2005-2010. MMWR Morb Mortal Wkly Rep 2011;60(35):1207-1212.
3. Centers for Disease Control and Prevention. Quitting smoking among adults, United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011 Nov 11;60(44):1513-1519 [FREE Full text] [Medline: 22071589]
4. Jamal A, Homa DM, O'Connor E, Babb SD, Caraballo RS, Singh T, et al. Current cigarette smoking among adults: United States, 2005-2014. MMWR Morb Mortal Wkly Rep 2015;64(44):1233-1240 [FREE Full text] [doi: 10.15585/mmwr.mm6444a2] [Medline: 26562061]
5. Mobile health (mHealth) for tobacco control. Geneva, Switzerland: World Health Organization 2014 URL: http://www. who.int/tobacco/mhealth/en/index.html [accessed 2016-07-24] [WebCite Cache ID 6blH0Qj1W]
6. McClure J, Hartzler A, Catz S. Design considerations for smoking cessation apps: feedback from nicotine dependence treatment providers and smokers. JMIR mHealth uHealth 2016;4(1).
7. The Smartphone Difference. Washington, DC: Pew Internet and American Life Project; 2015. URL: http://www. pewinternet.org/files/2015/03/PI_Smartphones_0401151.pdf [accessed 2016-07-24] [WebCite Cache ID 6blHQZkQB]
8. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 2011 Feb;13(2):94-102 [FREE Full text] [doi: 10.1093/ntr/ntq215] [Medline: 21147894]
9. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002 Sep 11;288(10):1260-1264. [Medline: 12215133]
10. Thorndike AN, Biener L, Rigotti NA. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002 Mar;92(3):437-442. [Medline: 11867326]
11. Paul CL, Walsh RA, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust N Z J Public Health 2003 Oct;27(5):491-495. [Medline: 14651392]
12. Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res 2011 May;13(5):361-368 [FREE Full text] [doi: 10.1093/ntr/ntr003] [Medline: 21350041]
13. Blak BT, Wilson K, Metcalfe M, Maguire A, Hards M. Evaluation of varenicline as an aid to smoking cessation in UK general practice-a THIN database study. Curr Med Res Opin 2010 Apr;26(4):861-870. [doi: 10.1185/03007990903526461] [Medline: 20144137]
14. Cooper TV, DeBon MW, Stockton M, Klesges RC, Steenbergh TA, Sherrill-Mittleman D, et al. Correlates of adherence with transdermal nicotine. Addict Behav 2004 Nov;29(8):1565-1578. [doi: 10.1016/j.addbeh.2004.02.033] [Medline: 15451124]
15. Alterman AI, Gariti P, Cook TG, Cnaan A. Nicodermal patch adherence and its correlates. Drug Alcohol Depend 1999 Jan 7;53(2):159-165. [Medline: 10080041]
16. Orleans CT, Resch N, Noll E, Keintz MK, Rimer BK, Brown TV, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. JAMA 1994 Feb 23;271(8):601-607. [Medline: 8301792]
17. McLaughlin T, Hogue SL, Stang PE. Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression. Am J Ther 2007;14(2):221-225. [doi: 10.1097/01.mjt.0000208273.80496.3f] [Medline: 17414593]
18. Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, et al. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. JAMA 2016 Jan 26;315(4):371-379. [doi: 10.1001/jama.2015.19284] [Medline: 26813210]
19. Swan GE, McClure JB, Jack LM, Zbikowski SM, Javitz HS, Catz SL, et al. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med 2010 May;38(5):482-490 [FREE Full text] [doi: 10.1016/j.amepre.2010.01.024] [Medline: 20409497]
20. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002 Sep;40(9):794-811. [doi: 10.1097/01.MLR.0000024612.61915.2D] [Medline: 12218770]
21. Drovandi AD, Chen CC, Glass BD. Adverse effects cause varenicline discontinuation: A meta-analysis. Curr Drug Saf 2016;11(1):78-85. [Medline: 26412667]
22. Fiore M, Jaén C, Baker T, Bailey W, Benowitz N, Curry S, et al. Treating tobacco use and dependence: update. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services Public Health Service; 2008:2008.
23. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991 Sep;86(9):1119-1127. [Medline: 1932883]
24. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005 Mar;100(3):299-303. [doi: 10.1111/j.1360-0443.2004.00995.x] [Medline: 15733243]
25. Zbikowski SM, Hapgood J, Smucker BS, McAfee T. Phone and web-based tobacco cessation treatment: real-world utilization patterns and outcomes for 11,000 tobacco users. J Med Internet Res 2008;10(5):e41 [FREE Full text] [doi: 10.2196/jmir.999] [Medline: 19017583]
26. Wu Q, Gilbody S, Peckham E, Brabyn S, Parrott S. Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis. Addiction 2016 Apr 4. [doi: 10.1111/add.13415] [Medline: 27043328]
27. Sterling LH, Windle SB, Filion KB, Touma L, Eisenberg MJ. Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5(2) [FREE Full text] [doi: 10.1161/JAHA.115.002849] [Medline: 26903004]
28. Cunningham FE, Hur K, Dong D, Miller DR, Zhang R, Wei X, et al. A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch. Addiction 2016 Jan 30. [doi: 10.1111/add.13329] [Medline: 26826702]
29. Smith RC, Amiaz R, Si T, Maayan L, Jin H, Boules S, et al. Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: a double-blind randomized trial. PLoS One 2016;11(1):e0143490 [FREE Full text] [doi: 10.1371/journal.pone.0143490] [Medline: 26730716]
30. Kotz D, Viechtbauer W, Simpson C, van Schayck OC, West R, Sheikh A. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study. Lancet Respir Med 2015 Oct;3(10):761-768 [FREE Full text] [doi: 10.1016/S2213-2600(15)00320-3] [Medline: 26355008]
31. Shewale AR, Borse MS, Brown JD, Li C. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers. Drug Alcohol Depend 2015 Sep 1;154:132-138. [doi: 10.1016/j.drugalcdep.2015.06.028] [Medline: 26169448]
32. Raich A, Ballbè M, Nieva G, Cano M, Fernández T, Bruguera E, et al. Safety of varenicline for smoking cessation in psychiatric and addicts patients. Subst Use Misuse 2016 Apr 15;51(5):649-657. [doi: 10.3109/10826084.2015.1133646] [Medline: 27050328]
33. Anthenelli R, Benowitz N, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a doubleblind, randomised, placebo-controlled clinical trial. Lancet 2016:e1-e14.
34. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4(2):149-159.
35. Zeng EY, Vilardaga R, Heffner JL, Mull KE, Bricker JB. Predictors of utilization of a novel smoking cessation smartphone app. Telemed J E Health 2015 Jul 14. [doi: 10.1089/tmj.2014.0232] [Medline: 26171733]
36. Buller DB, Borland R, Bettinghaus EP, Shane JH, Zimmerman DE. Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation. Telemed J E Health 2014 Mar;20(3):206-214 [FREE Full text] [doi: 10.1089/tmj.2013.0169] [Medline: 24350804]
37. Ubhi HK, Michie S, Kotz D, Wong WC, West R. A mobile app to aid smoking cessation: preliminary evaluation of SmokeFree28. J Med Internet Res 2015;17(1):e17 [FREE Full text] [doi: 10.2196/jmir.3479] [Medline: 25596170]
38. Bricker JB, Mull KE, Kientz JA, Vilardaga R, Mercer LD, Akioka KJ, et al. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend 2014 Oct 1;143:87-94. [doi: 10.1016/j.drugalcdep.2014.07.006] [Medline: 25085225]
39. Ploderer B, Smith W, Pearce J, Borland R. A mobile app offering distractions and tips to cope with cigarette craving: a qualitative study. JMIR Mhealth Uhealth 2014;2(2):e23 [FREE Full text] [doi: 10.2196/mhealth.3209] [Medline: 25099632]
40. Garrison KA, Pal P, Rojiani R, Dallery J, O'Malley SS, Brewer JA. A randomized controlled trial of smartphone-based mindfulness training for smoking cessation: a study protocol. BMC Psychiatry 2015;15:83 [FREE Full text] [doi: 10.1186/s12888-015-0468-z] [Medline: 25884648]
41. Baskerville NB, Struik LL, Hammond D, Guindon GE, Norman CD, Whittaker R, et al. Effect of a mobile phone intervention on quitting smoking in a young adult population of smokers: randomized controlled trial study protocol. JMIR Res Protoc 2015;4(1):e10 [FREE Full text] [doi: 10.2196/resprot.3823] [Medline: 25599695]
42. BinDhim NF, McGeechan K, Trevena L. Assessing the effect of an interactive decision-aid smartphone smoking cessation application (app) on quit rates: a double-blind automated randomised control trial protocol. BMJ Open 2014;4(7):e005371 [FREE Full text] [doi: 10.1136/bmjopen-2014-005371] [Medline: 25037644]
43. Valdivieso-López E, Flores-Mateo G, Molina-Gómez J, Rey-Reñones C, Barrera UM, Duch J, et al. Efficacy of a mobile application for smoking cessation in young people: study protocol for a clustered, randomized trial. BMC Public Health 2013;13:704 [FREE Full text] [doi: 10.1186/1471-2458-13-704] [Medline: 23915067]
44. Hassandra M, Lintunen T, Kettunen T, Vanhala M, Toivonen H, Kinnunen K, et al. Effectiveness of a Mobile Phone app for adults that uses physical activity as a tool to manage cigarette craving after smoking cessation: a study protocol for a randomized controlled trial. JMIR Res Protoc 2015;4(4):e125 [FREE Full text] [doi: 10.2196/resprot.4600] [Medline: 26494256]
45. Hoeppner BB, Hoeppner SS, Seaboyer L, Schick MR, Wu GW, Bergman BG, et al. How smart are smartphone apps for smoking cessation? A content analysis. Nicotine Tob Res 2015 Jun 4. [doi: 10.1093/ntr/ntv117] [Medline: 26045249]
46. Krebs P, Tseng T, Pham H, Wong S, Sherman SE, Shelley D, et al. Formative evaluation of a text messaging intervention to promote varenicline adherence among tobacco-dependent persons with HIV. J Health Commun 2015;20(9):1021-1025. [doi: 10.1080/10810730.2015.1018595] [Medline: 26132516]